Analysis of Minimal Residual Disease in Follicular Lymphoma Patients in Gadolin, a Phase III Study of Obinutuzumab Plus Bendamustine Versus Bendamustine in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

被引：15

作者：

Pott, Christiane ^{[1
]}

Belada, David ^{[2
]}

Danesi, Nathalie ^{[3
]}

Fingerle-Rowson, Guenter ^{[3
]}

Gribben, John ^{[4
]}

Harbron, Chris ^{[3
]}

Hoster, Eva ^{[5
]}

Kahl, Brad S. ^{[6
]}

Mundt, Kirsten ^{[7
]}

Sebban, Catherine ^{[8
]}

Sehn, Laurie H. ^{[9
,10
]}

Cheson, Bruce D. ^{[11
]}

机构：

[1] Univ Hosp Schleswig Holstein, Kiel, Germany

[2] IV Interni Hematol Klin, Hematol Dept 4, Hradec Kralove, Czech Republic

[3] F Hoffmann La Roche Ltd, Basel, Switzerland

[4] Queen Mary Univ London, Barts Canc Inst, Ctr Haemato Oncol, London, England

[5] Univ Hosp Grosshadern, Munich, Germany

[6] Washington Univ, St Louis, MO USA

[7] Genentech Inc, San Francisco, CA 94080 USA

[8] Univ Lyon, Hematol, Lyon, France

[9] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

[10] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[11] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

来源：

关键词：

D O I：

10.1182/blood.V126.23.3978.3978

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4